Robert Jacks

Robert Jacks

Directeur Général chez
Sparrow Pharmaceuticals, Inc.
Health Technology
Consumer Services
Finance

Profil

Robert Jacks was the founder of Symbiomix Therapeutics LLC, founded in 2012, holding the title of President & Chief Financial Officer.
Mr. Jacks is currently the President, Chief Executive Officer & Director at Sparrow Pharmaceuticals, Inc. since 2021.
Former positions include President, Chief Executive Officer & Director at Indalo Therapeutics, Inc., Principal at Pfizer Inc., Vice President-Business Development at Paramount BioSciences LLC, and Vice President & Head-Development at ACT Biotech, Inc. Education includes an undergraduate degree from Duke University, a graduate degree from Stanford University, and an MBA from Columbia Business School.

Postes actifs de Robert Jacks

SociétésPosteDébut
Directeur Général 01/01/2021

Anciens postes connus de Robert Jacks

SociétésPosteFin
Directeur Général -
Fondateur -
Corporate Officer/Principal -
PFIZER INC. Corporate Officer/Principal -
Private Equity Investor -
Voir l'expérience en détail de Robert Jacks

Formation de Robert Jacks

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Robert Jacks
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇